Healthcare -
Biotechnology - NASDAQ - US
$ 2.04
-0.971 %
$ 56.1 M
Market Cap
-2.43
P/E
Price Target
Average
243.14%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
129.19%
Net Income
Estimate
71.78%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Immix Biopharma, Inc.
Wall Street analysts predict an average 1-year price target for IMMX of $7 , with forecasts ranging from
a
low of
$7 to a high of $7 .
IMMX Lowest Price Target
Wall Street Target
7 USD
243.14%
IMMX Average Price Target
Wall Street Target
7 USD
243.14%
IMMX Highest Price Target
Wall Street Target
7 USD
243.14%
REVENUE FORECAST
Revenue Forecast Chart IMMX
EBIT FORECAST
EBIT Forecast Chart IMMX
NET INCOME FORECAST
Net Income Chart IMMX